About femasys inc - FEMY
Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.
FEMY At a Glance
Femasys, Inc.
3950 Johns Creek Court
Suwanee, Georgia 30024
| Phone | 1-770-500-3910 | Revenue | 1.63M | |
| Industry | Electronic Equipment/Instruments | Net Income | -18,816,628.00 | |
| Sector | Electronic Technology | 2024 Sales Growth | 51.973% | |
| Fiscal Year-end | 12 / 2025 | Employees | 71 | |
| View SEC Filings |
FEMY Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 15.036 |
| Price to Book Ratio | 11.148 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.684 |
| Enterprise Value to Sales | 17.485 |
| Total Debt to Enterprise Value | 0.261 |
FEMY Efficiency
| Revenue/Employee | 22,945.183 |
| Income Per Employee | -265,022.93 |
| Receivables Turnover | 3.336 |
| Total Asset Turnover | 0.081 |
FEMY Liquidity
| Current Ratio | 0.935 |
| Quick Ratio | 0.58 |
| Cash Ratio | 0.402 |
FEMY Profitability
| Gross Margin | 13.026 |
| Operating Margin | -1,091.751 |
| Pretax Margin | -1,154.437 |
| Net Margin | -1,155.026 |
| Return on Assets | -93.613 |
| Return on Equity | -182.182 |
| Return on Total Capital | -193.056 |
| Return on Invested Capital | -132.189 |
FEMY Capital Structure
| Total Debt to Total Equity | 322.957 |
| Total Debt to Total Capital | 76.357 |
| Total Debt to Total Assets | 59.801 |
| Long-Term Debt to Equity | 65.878 |
| Long-Term Debt to Total Capital | 15.576 |